Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Zyprexa
Marketing
Alkermes' Lybalvi a new litmus test for mental illness marketing
Marketing mental illness treatments is a challenge in pharma, and Alkermes is navigating COVID, stigma and a major generics market for Lybalvi.
Ben Adams
Feb 24, 2022 10:20am
Alkermes gains FDA nod for schizophrenia drug Lybalvi
Jun 1, 2021 9:42am
Lilly CEO to pharma: Stop talking and get going on pricing
Jan 10, 2018 7:33am
Senator blasts 'revolving door' in Washington at Azar hearing
Nov 29, 2017 12:35pm
FDA warns of potentially fatal skin reactions to Lilly's Zyprexa
May 11, 2016 8:42am
FDA nixes long-acting Zyprexa
Feb 28, 2008 6:59am
